Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Identify the ideal low-cost index funds for retirement using transparent criteria and performance benchmarks to guide your choices.
27,037 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
American Express trades around $315 as Q1 2026 results highlight growth in card member spending and improving credit ...
The latest Beige Book shows inflation pressing higher in most districts, led by energy costs and shipping pressures. ...
The memory ETF DRAM fell 15% in one day as a guidance miss sparked a broader selloff, underscoring the risk of a conc...
Oracle’s stock is enduring its worst stretch in a generation as the AI debate intensifies, cloud growth battles margi...
Palantir stock soared today as investors priced in a mix of solid results, new government and enterprise wins, and a ...
ETH activity climbs to record levels in Q1 2026 even as price declines and fees shrink. Analysts call it a classic re...
A newly opened St. Bernard Museum near Switzerland’s Great St. Bernard Pass draws visitors and nudges budget planning...
A reported plan for Apple to source memory chips from a Chinese supplier could upend Micron’s mobile business and cha...
A fresh analysis tests whether a $10,000 crypto investment can turn into $1 million by 2030, focusing on BTC, ETH, XR...
When a state tightens its grip on fraud, honest families feel the impact first. Alaska's Medicaid crackdown underscor...
President Trump orders a tight 24-day sprint for Senate approval of the CLARITY Act, aiming to restore U.S. leadershi...